NCT04252963View on ClinicalTrials.gov

Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)

PHASE4UnknownINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

November 2, 2018

Primary Completion Date

February 28, 2021

Study Completion Date

May 31, 2021

Conditions
Acute Upper Respiratory InfectionAcute Bronchitis
Interventions
DRUG

MUCOLASE tablet (streptokinase • streptodornase)

streptokinase • streptodornase 5mg

DRUG

Placebo

Placebo of MUCOLASE tablet

Trial Locations (1)

Unknown

RECRUITING

Konkuk University Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04252963 - Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) | Biotech Hunter | Biotech Hunter